Lumibird SA (PA:LBIRD) — Market Cap & Net Worth
Market Cap & Net Worth: Lumibird SA (LBIRD)
Lumibird SA (PA:LBIRD) has a market capitalization of $489.86 Million (€419.00 Million) as of June 21, 2026. Listed on the PA stock exchange, this France-based company holds position #12488 globally and #191 in its home market, demonstrating a 4.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lumibird SA's stock price €24.65 by its total outstanding shares 22065629 (22.07 Million). Review LBIRD current and long-term liabilities to assess the company's total debt and financial obligations.
Lumibird SA Market Cap History: 2015 to 2026
Lumibird SA's market capitalization history from 2015 to 2026. Data shows growth from $73.40 Million to $635.90 Million (21.65% CAGR).
Index Memberships
Lumibird SA is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Health Care
FRHC
|
$255.24 Billion | 0.19% | #15 of 36 |
Weight: Lumibird SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lumibird SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lumibird SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.39x
Lumibird SA's market cap is 2.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
39.06x
Lumibird SA's market cap is 39.06 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $83.15 Million | $63.97 Million | $646.00K | 1.30x | 128.72x |
| 2017 | $180.94 Million | $37.82 Million | $1.74 Million | 4.78x | 103.99x |
| 2018 | $283.77 Million | $101.80 Million | $8.07 Million | 2.79x | 35.14x |
| 2019 | $392.11 Million | $112.65 Million | $8.82 Million | 3.48x | 44.46x |
| 2020 | $362.19 Million | $129.50 Million | $5.64 Million | 2.80x | 64.24x |
| 2021 | $620.42 Million | $162.47 Million | $13.86 Million | 3.82x | 44.77x |
| 2022 | $427.20 Million | $194.29 Million | $11.35 Million | 2.20x | 37.63x |
| 2023 | $314.21 Million | $206.55 Million | $7.13 Million | 1.52x | 44.09x |
| 2024 | $241.46 Million | $210.06 Million | $5.70 Million | 1.15x | 42.40x |
| 2025 | $546.90 Million | $228.53 Million | $14.00 Million | 2.39x | 39.06x |
Competitor Companies of LBIRD by Market Capitalization
Companies near Lumibird SA in the global market cap rankings as of June 21, 2026.
Key companies related to Lumibird SA by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #131 globally with a market cap of $174.56 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $125.14 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #622 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.56 Billion | $464.61 |
| #189 | Danaher Corporation | NYSE:DHR | $125.14 Billion | $177.17 |
| #622 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $562.09 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Lumibird SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Lumibird SA's market cap moved from $73.40 Million to $ 635.90 Million, with a yearly change of 21.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €635.90 Million | +16.27% |
| 2025 | €546.90 Million | +126.50% |
| 2024 | €241.46 Million | -23.15% |
| 2023 | €314.21 Million | -26.45% |
| 2022 | €427.20 Million | -31.14% |
| 2021 | €620.42 Million | +71.30% |
| 2020 | €362.19 Million | -7.63% |
| 2019 | €392.11 Million | +38.18% |
| 2018 | €283.77 Million | +56.83% |
| 2017 | €180.94 Million | +117.60% |
| 2016 | €83.15 Million | +13.28% |
| 2015 | €73.40 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of Lumibird SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $489.86 Million USD |
| MoneyControl | $489.86 Million USD |
| MarketWatch | $489.86 Million USD |
| marketcap.company | $489.86 Million USD |
| Reuters | $489.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lumibird SA
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates through Photonics and Medical divisions. It offers fiber lasers and amplifiers, high power fiber lasers, and solid-state lasers, laser diodes and components; and doppler wind LiDAR, … Read more